New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
OptimizeRx Corporation
OPRX
Shape
US Flag

NASDAQ

139M

Medical - Healthcare Information Services

Next Earning date - 04 Nov 2024

139M

Medical - Healthcare Information Services

Next Earning date - 04 Nov 2024

7.59USD
Shape0.39 ( 5.42%)
favorite-chart

Relative Strenght

19
favorite-chart

Volume Buzz

117%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

54%

Quote Panel

Shape
Updated October 3, 2024
1W -2.06 % 1M 0.80 % 3M -23.87 % 1Y 4.40 %

Key Metrics

Shape
  • Market Cap

    139.06M


  • Shares Outstanding

    18.32M


  • Share in Float

    15.89M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    7.59


  • Average Volume

    116936


  • Beta

    1.273


  • Range

    6.84-16.65


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.optimizerx.com


  • Sector

    Healthcare


Fundamentals

Shape

63.25x

P/E Ratio

1.67x

P/S Ratio

1.15x

P/B Ratio

0.3

Debt/Equity

-21.5%

Net Margin

$-1.0

EPS

How OPRX compares to sector?

P/E Ratio

Relative Strength

Shape

OPRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$114M

Shape504%

2025-Revenue

$0.60

Shape-173%

2025-EPS

$8M

Shape-213%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

JMP Securities

initialise

Previous: Market Outperform

2024-04-04

Now: Outperform

JMP Securities

initialise

Previous: Not converted

2024-04-04

Now: Market Outperform

SVB Leerink

initialise

Previous: Not converted

2022-07-15

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-22%

0.07
vs 0.09

Q4.22

arrow
arrow

+14%

0.25
vs 0.22

Q1.23

arrow
arrow

N/A

NA
vs NA

Q2.23

arrow
arrow

N/A

-0.01
vs 0.04

Q3.23

arrow
arrow

+29%

0.09
vs 0.07

Q4.23

arrow
arrow

-96%

0.01
vs 0.25

Q1.24

arrow
arrow

N/A

NA
vs NA

Q2.24

arrow
arrow

+300%

0.02
vs -0.01

Q3.24

arrow
arrow

-34%

0.06
vs 0.09

Q4.24

arrow
arrow

+3683%

0.38
vs 0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-6%

15.1M  vs 16.1M

Q4.22

arrow
arrow

-3%

19.7M  vs 20.3M

Q1.23

arrow
arrow

-5%

13M  vs 13.7M

Q2.23

arrow
arrow

-1%

13.8M  vs 14M

Q3.23

arrow
arrow

+8%

16.3M  vs 15.1M

Q4.23

arrow
arrow

+44%

28.4M  vs 19.7M

Q1.24

arrow
arrow

+51%

19.7M  vs 13M

Q2.24

arrow
arrow

+36%

18.8M  vs 13.8M

Q3.24

arrow
arrow

+53%

25M  vs 16.3M

Q4.24

arrow
arrow

+31%

37.1M  vs 28.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-2%

-0.02
vs -0.03

Q4.22

arrow
arrow

+0%

0
vs -0.02

Q1.23

arrow
arrow

-5%

-0.05
vs 0

Q2.23

arrow
arrow

-4%

-0.04
vs -0.05

Q3.23

arrow
arrow

-2%

-0.02
vs -0.04

Q4.23

arrow
arrow

-3%

-0.03
vs -0.02

Q1.24

arrow
arrow

-6%

-0.06
vs -0.03

Q2.24

arrow
arrow

-3%

-0.03
vs -0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

132

132
vs 149

-11%

Q4.22

arrow
arrow

134

134
vs 132

2%

Q1.23

arrow
arrow

115

115
vs 134

-14%

Q2.23

arrow
arrow

107

107
vs 115

-7%

Q3.23

arrow
arrow

99

99
vs 107

-7%

Q4.23

arrow
arrow

102

102
vs 99

3%

Q1.24

arrow
arrow

99

99
vs 102

-3%

Q2.24

arrow
arrow

94

94
vs 99

-5%

Earnings Growth

Latest News